

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of meiosis (GO:0040020) | 8.48249457 |
| 2 | female gamete generation (GO:0007292) | 8.05825370 |
| 3 | mitotic chromosome condensation (GO:0007076) | 7.71954011 |
| 4 | retinal cone cell development (GO:0046549) | 7.68366000 |
| 5 | positive regulation of histone H3-K4 methylation (GO:0051571) | 7.60717531 |
| 6 | negative regulation of meiosis (GO:0045835) | 7.35152093 |
| 7 | multicellular organism reproduction (GO:0032504) | 7.22890239 |
| 8 | oocyte development (GO:0048599) | 7.00863478 |
| 9 | regulation of histone H3-K9 methylation (GO:0051570) | 6.91556732 |
| 10 | regulation of meiosis I (GO:0060631) | 6.85448824 |
| 11 | regulation of histone H3-K27 methylation (GO:0061085) | 6.83626004 |
| 12 | regulation of meiotic cell cycle (GO:0051445) | 6.74525591 |
| 13 | establishment of spindle orientation (GO:0051294) | 6.73745107 |
| 14 | attachment of spindle microtubules to kinetochore (GO:0008608) | 6.62610651 |
| 15 | establishment of spindle localization (GO:0051293) | 6.61746660 |
| 16 | protein localization to kinetochore (GO:0034501) | 6.46291065 |
| 17 | regulation of steroid hormone secretion (GO:2000831) | 6.42118804 |
| 18 | glycine transport (GO:0015816) | 6.40744169 |
| 19 | protein kinase C signaling (GO:0070528) | 6.15461739 |
| 20 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 6.04632757 |
| 21 | histone H2A monoubiquitination (GO:0035518) | 5.96129337 |
| 22 | mitotic metaphase plate congression (GO:0007080) | 5.89310580 |
| 23 | protein localization to chromosome, centromeric region (GO:0071459) | 5.54862810 |
| 24 | positive regulation of humoral immune response (GO:0002922) | 5.54269478 |
| 25 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.52277226 |
| 26 | regulation of retinoic acid receptor signaling pathway (GO:0048385) | 5.39357637 |
| 27 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 5.30474697 |
| 28 | regulation of cell maturation (GO:1903429) | 5.07533076 |
| 29 | histone H2A ubiquitination (GO:0033522) | 5.06447981 |
| 30 | metaphase plate congression (GO:0051310) | 5.05940606 |
| 31 | gene silencing by RNA (GO:0031047) | 4.96699638 |
| 32 | piRNA metabolic process (GO:0034587) | 4.91377720 |
| 33 | reproduction (GO:0000003) | 4.79625015 |
| 34 | L-amino acid import (GO:0043092) | 4.72554847 |
| 35 | maturation of 5.8S rRNA (GO:0000460) | 4.69742516 |
| 36 | protein localization to chromosome (GO:0034502) | 4.59156433 |
| 37 | positive regulation of histone methylation (GO:0031062) | 4.59071387 |
| 38 | positive regulation of gastrulation (GO:2000543) | 4.59000950 |
| 39 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.56896759 |
| 40 | regulation of steroid hormone biosynthetic process (GO:0090030) | 4.56409409 |
| 41 | negative regulation of histone methylation (GO:0031061) | 4.55269757 |
| 42 | * meiotic cell cycle (GO:0051321) | 4.52641019 |
| 43 | regulation of mitotic spindle organization (GO:0060236) | 4.45768354 |
| 44 | regulation of histone H3-K4 methylation (GO:0051569) | 4.44391468 |
| 45 | positive regulation of reproductive process (GO:2000243) | 4.37619536 |
| 46 | mitotic sister chromatid segregation (GO:0000070) | 4.36183566 |
| 47 | establishment of chromosome localization (GO:0051303) | 4.33279315 |
| 48 | base-excision repair, AP site formation (GO:0006285) | 4.28778934 |
| 49 | protein K6-linked ubiquitination (GO:0085020) | 4.28207424 |
| 50 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 4.26433498 |
| 51 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 4.26433498 |
| 52 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 4.26149122 |
| 53 | positive regulation of chromosome segregation (GO:0051984) | 4.20378822 |
| 54 | centriole replication (GO:0007099) | 4.19145870 |
| 55 | phosphorelay signal transduction system (GO:0000160) | 4.18396798 |
| 56 | CENP-A containing nucleosome assembly (GO:0034080) | 4.16814218 |
| 57 | oocyte maturation (GO:0001556) | 4.16407805 |
| 58 | regulation of histone methylation (GO:0031060) | 4.12866525 |
| 59 | chromatin remodeling at centromere (GO:0031055) | 4.02698055 |
| 60 | synapsis (GO:0007129) | 4.01603300 |
| 61 | primitive streak formation (GO:0090009) | 3.96174733 |
| 62 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.93864634 |
| 63 | binding of sperm to zona pellucida (GO:0007339) | 3.91460176 |
| 64 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 3.90600933 |
| 65 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 3.90600933 |
| 66 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 3.90600933 |
| 67 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.90010592 |
| 68 | one-carbon metabolic process (GO:0006730) | 3.89737741 |
| 69 | chromosome segregation (GO:0007059) | 3.87776340 |
| 70 | regulation of sister chromatid cohesion (GO:0007063) | 3.84426863 |
| 71 | negative regulation of hormone metabolic process (GO:0032351) | 3.81555097 |
| 72 | histone exchange (GO:0043486) | 3.80574537 |
| 73 | negative regulation of reproductive process (GO:2000242) | 3.78896196 |
| 74 | kinetochore organization (GO:0051383) | 3.78466064 |
| 75 | stress granule assembly (GO:0034063) | 3.75059620 |
| 76 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.74943861 |
| 77 | DNA replication-independent nucleosome organization (GO:0034724) | 3.74943861 |
| 78 | fertilization (GO:0009566) | 3.74864106 |
| 79 | regulation of spindle organization (GO:0090224) | 3.71314681 |
| 80 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.71073316 |
| 81 | male meiosis I (GO:0007141) | 3.68196665 |
| 82 | DNA damage induced protein phosphorylation (GO:0006975) | 3.66764139 |
| 83 | mitotic nuclear envelope disassembly (GO:0007077) | 3.66511925 |
| 84 | membrane tubulation (GO:0097320) | 3.65296568 |
| 85 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.65032157 |
| 86 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.65032157 |
| 87 | DNA methylation (GO:0006306) | 3.62774603 |
| 88 | DNA alkylation (GO:0006305) | 3.62774603 |
| 89 | microtubule nucleation (GO:0007020) | 3.62495872 |
| 90 | single fertilization (GO:0007338) | 3.59422703 |
| 91 | translesion synthesis (GO:0019985) | 3.57786901 |
| 92 | regulation of RNA export from nucleus (GO:0046831) | 3.57566004 |
| 93 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 3.56323650 |
| 94 | sister chromatid segregation (GO:0000819) | 3.55118823 |
| 95 | spindle checkpoint (GO:0031577) | 3.53812561 |
| 96 | positive regulation of megakaryocyte differentiation (GO:0045654) | 3.53566296 |
| 97 | kinetochore assembly (GO:0051382) | 3.51003367 |
| 98 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.47903884 |
| 99 | gene silencing (GO:0016458) | 3.47870401 |
| 100 | membrane disassembly (GO:0030397) | 3.46735126 |
| 101 | nuclear envelope disassembly (GO:0051081) | 3.46735126 |
| 102 | cellular response to pH (GO:0071467) | 3.45931788 |
| 103 | negative regulation of histone modification (GO:0031057) | 3.43313354 |
| 104 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 3.42280908 |
| 105 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.41559804 |
| 106 | citrulline biosynthetic process (GO:0019240) | 3.41479702 |
| 107 | negative regulation of nuclear division (GO:0051784) | 3.41218760 |
| 108 | DNA replication checkpoint (GO:0000076) | 3.40781753 |
| 109 | type B pancreatic cell development (GO:0003323) | 3.40633213 |
| 110 | regulation of corticosteroid hormone secretion (GO:2000846) | 3.39789583 |
| 111 | N-terminal protein amino acid acetylation (GO:0006474) | 3.38198083 |
| 112 | oogenesis (GO:0048477) | 3.37881437 |
| 113 | aggressive behavior (GO:0002118) | 3.37873124 |
| 114 | * regulation of DNA methylation (GO:0044030) | 3.35650170 |
| 115 | chaperone-mediated protein transport (GO:0072321) | 3.35383699 |
| 116 | hyperosmotic salinity response (GO:0042538) | 3.34815501 |
| 117 | mitotic spindle checkpoint (GO:0071174) | 3.33668559 |
| 118 | glycerophospholipid catabolic process (GO:0046475) | 3.33019555 |
| 119 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 3.31745608 |
| 120 | positive regulation of hormone biosynthetic process (GO:0046886) | 3.30952197 |
| 121 | meiotic chromosome segregation (GO:0045132) | 3.29392708 |
| 122 | notochord development (GO:0030903) | 3.28667481 |
| 123 | regulation of autophagic vacuole assembly (GO:2000785) | 3.28404117 |
| 124 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 3.27794251 |
| 125 | amino acid import (GO:0043090) | 3.25261604 |
| 126 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.24937331 |
| 127 | labyrinthine layer development (GO:0060711) | 3.22531744 |
| 128 | regulation of exit from mitosis (GO:0007096) | 3.22312320 |
| 129 | histone phosphorylation (GO:0016572) | 3.21869324 |
| 130 | regulation of uterine smooth muscle contraction (GO:0070472) | 3.20232282 |
| 131 | negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240) | 3.20083475 |
| 132 | negative regulation of signal transduction in absence of ligand (GO:1901099) | 3.20083475 |
| 133 | interkinetic nuclear migration (GO:0022027) | 3.19933487 |
| 134 | regulation of spindle checkpoint (GO:0090231) | 3.19811585 |
| 135 | cytoskeleton-dependent cytokinesis (GO:0061640) | 3.19524452 |
| 136 | negative regulation of chromosome segregation (GO:0051985) | 3.19518054 |
| 137 | regulation of reproductive process (GO:2000241) | 3.19405995 |
| 138 | regulation of G2/M transition of mitotic cell cycle (GO:0010389) | 3.18998818 |
| 139 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 3.15373535 |
| 140 | regulation of chromatin silencing (GO:0031935) | 3.14293123 |
| 141 | meiosis I (GO:0007127) | 3.13991163 |
| 142 | regulation of female receptivity (GO:0045924) | 3.13615170 |
| 143 | sperm-egg recognition (GO:0035036) | 3.13515759 |
| 144 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 3.13508071 |
| 145 | response to acidic pH (GO:0010447) | 3.13128135 |
| 146 | DNA methylation involved in gamete generation (GO:0043046) | 3.12987421 |
| 147 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 3.12916562 |
| 148 | male meiosis (GO:0007140) | 3.08754656 |
| 149 | regulation of chromosome segregation (GO:0051983) | 3.08405196 |
| 150 | regulation of acrosome reaction (GO:0060046) | 3.06585874 |
| 151 | nuclear envelope organization (GO:0006998) | 3.06051650 |
| 152 | erythrocyte development (GO:0048821) | 3.05689558 |
| 153 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.05160119 |
| 154 | negative regulation of cell division (GO:0051782) | 3.02187053 |
| 155 | muscle cell migration (GO:0014812) | 3.02149861 |
| 156 | mitotic spindle assembly checkpoint (GO:0007094) | 3.01263657 |
| 157 | chromosome condensation (GO:0030261) | 3.00706974 |
| 158 | folic acid metabolic process (GO:0046655) | 2.99944120 |
| 159 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.99756991 |
| 160 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.99271020 |
| 161 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.99271020 |
| 162 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.99271020 |
| 163 | negative regulation of sister chromatid segregation (GO:0033046) | 2.99271020 |
| 164 | regulation of mitotic sister chromatid separation (GO:0010965) | 2.96393267 |
| 165 | regulation of mitotic sister chromatid segregation (GO:0033047) | 2.96393267 |
| 166 | regulation of sister chromatid segregation (GO:0033045) | 2.96393267 |
| 167 | regulation of nuclear division (GO:0051783) | 2.95917249 |
| 168 | regulation of female gonad development (GO:2000194) | 13.2265240 |
| 169 | negative regulation of meiotic cell cycle (GO:0051447) | 10.2386730 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 6.89145324 |
| 2 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 4.86407814 |
| 3 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 4.18294752 |
| 4 | AR_21909140_ChIP-Seq_LNCAP_Human | 3.91981468 |
| 5 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.71002505 |
| 6 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.60443269 |
| 7 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.44911823 |
| 8 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 3.41620332 |
| 9 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 3.41620332 |
| 10 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 3.41620332 |
| 11 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 3.40549259 |
| 12 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.31396242 |
| 13 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.19389855 |
| 14 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 3.04816044 |
| 15 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.82249478 |
| 16 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.60655769 |
| 17 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.50249443 |
| 18 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 2.49575005 |
| 19 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.41712937 |
| 20 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.34737249 |
| 21 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.32493808 |
| 22 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 2.26461260 |
| 23 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 2.14149649 |
| 24 | MYC_18940864_ChIP-ChIP_HL60_Human | 2.11308246 |
| 25 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 2.08489905 |
| 26 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.05779585 |
| 27 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 2.01521512 |
| 28 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.89547479 |
| 29 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.85211341 |
| 30 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.83542041 |
| 31 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.80897100 |
| 32 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.79329973 |
| 33 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.76865144 |
| 34 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.69769419 |
| 35 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.67237838 |
| 36 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.54427629 |
| 37 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.52308107 |
| 38 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.49030837 |
| 39 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.43499093 |
| 40 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.36668510 |
| 41 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.35877824 |
| 42 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.34276236 |
| 43 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.31178758 |
| 44 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.31015430 |
| 45 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.29715709 |
| 46 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.29712767 |
| 47 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.28905861 |
| 48 | GF1B_26923725_Chip-Seq_HPCs_Mouse | 1.28454247 |
| 49 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.25556458 |
| 50 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.23060011 |
| 51 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.22317680 |
| 52 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.18985271 |
| 53 | * CEBPB_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.16403475 |
| 54 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.15039388 |
| 55 | EWS_26573619_Chip-Seq_HEK293_Human | 1.13066865 |
| 56 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.12741917 |
| 57 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.12370484 |
| 58 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.12324647 |
| 59 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.11880774 |
| 60 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.10666860 |
| 61 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10341799 |
| 62 | TCF4_23295773_ChIP-Seq_U87_Human | 1.10316415 |
| 63 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.09655362 |
| 64 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09501285 |
| 65 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.09459215 |
| 66 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.09129339 |
| 67 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.08618317 |
| 68 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.08611023 |
| 69 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.08361157 |
| 70 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.06460548 |
| 71 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.05140673 |
| 72 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.04784036 |
| 73 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.04437693 |
| 74 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.03449692 |
| 75 | FUS_26573619_Chip-Seq_HEK293_Human | 1.02599490 |
| 76 | STAT3_23295773_ChIP-Seq_U87_Human | 1.02037711 |
| 77 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.01365489 |
| 78 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.00170070 |
| 79 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.99228515 |
| 80 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.98740479 |
| 81 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.98218049 |
| 82 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.98005350 |
| 83 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.97730615 |
| 84 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97333154 |
| 85 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96012389 |
| 86 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 0.95200263 |
| 87 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.94631046 |
| 88 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.94075487 |
| 89 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.93859084 |
| 90 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.93401092 |
| 91 | * CBP_20019798_ChIP-Seq_JUKART_Human | 0.93401092 |
| 92 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.93059708 |
| 93 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.92957331 |
| 94 | VDR_22108803_ChIP-Seq_LS180_Human | 0.92906676 |
| 95 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.92762092 |
| 96 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.92292587 |
| 97 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.91957757 |
| 98 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.91556575 |
| 99 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.90780416 |
| 100 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.90645330 |
| 101 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.90551593 |
| 102 | * AR_25329375_ChIP-Seq_VCAP_Human | 0.90054633 |
| 103 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.89604085 |
| 104 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.88860607 |
| 105 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.88085557 |
| 106 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.86093971 |
| 107 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.85708800 |
| 108 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.85416965 |
| 109 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.85359707 |
| 110 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85177526 |
| 111 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.85177526 |
| 112 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84616272 |
| 113 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.84466595 |
| 114 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.83427501 |
| 115 | NFYA_21822215_ChIP-Seq_K562_Human | 0.83031524 |
| 116 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.82409292 |
| 117 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82362696 |
| 118 | CBP_21632823_ChIP-Seq_H3396_Human | 0.82017775 |
| 119 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.81020408 |
| 120 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.80268684 |
| 121 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.79128231 |
| 122 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.78871498 |
| 123 | SETDB1_19884257_ChIP-Seq_MESCs_Mouse | 0.77389480 |
| 124 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.77344760 |
| 125 | GATA3_26560356_Chip-Seq_TH1_Human | 0.77013217 |
| 126 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.76508459 |
| 127 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.76000406 |
| 128 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.75903991 |
| 129 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.75736795 |
| 130 | CJUN_26792858_Chip-Seq_BT549_Human | 0.75157108 |
| 131 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.75082132 |
| 132 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.73306604 |
| 133 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.72681086 |
| 134 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.72375387 |
| 135 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.72085640 |
| 136 | MYC_22102868_ChIP-Seq_BL_Human | 0.71713400 |
| 137 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.71353626 |
| 138 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.71353626 |
| 139 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.71203970 |
| 140 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.70786644 |
| 141 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.70770295 |
| 142 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.70042425 |
| 143 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.69876435 |
| 144 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.69186818 |
| 145 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.68039623 |
| 146 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.66662350 |
| 147 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.65599311 |
| 148 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.65464397 |
| 149 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.65210716 |
| 150 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.65018105 |
| 151 | * GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.64383596 |
| 152 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.62507209 |
| 153 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.60702467 |
| 154 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.60281761 |
| 155 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.59944200 |
| 156 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.58135616 |
| 157 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.56279429 |
| 158 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.55179403 |
| 159 | BCL6_25482012_ChIP-Seq_CML-JURL-MK1_Human | 0.54434566 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003718_maternal_effect | 8.41253152 |
| 2 | MP0005451_abnormal_body_composition | 7.89117669 |
| 3 | MP0002653_abnormal_ependyma_morphology | 4.49833331 |
| 4 | MP0005395_other_phenotype | 3.74258567 |
| 5 | MP0008057_abnormal_DNA_replication | 3.69642246 |
| 6 | MP0008789_abnormal_olfactory_epithelium | 3.60719215 |
| 7 | MP0003646_muscle_fatigue | 3.46659371 |
| 8 | MP0005499_abnormal_olfactory_system | 3.38170048 |
| 9 | MP0005394_taste/olfaction_phenotype | 3.38170048 |
| 10 | MP0003699_abnormal_female_reproductive | 3.24678301 |
| 11 | MP0010094_abnormal_chromosome_stability | 3.11457264 |
| 12 | MP0001119_abnormal_female_reproductive | 3.09276636 |
| 13 | MP0002138_abnormal_hepatobiliary_system | 2.85938686 |
| 14 | MP0003111_abnormal_nucleus_morphology | 2.82477085 |
| 15 | MP0003879_abnormal_hair_cell | 2.82017806 |
| 16 | MP0003077_abnormal_cell_cycle | 2.64285397 |
| 17 | MP0003693_abnormal_embryo_hatching | 2.59597062 |
| 18 | MP0004264_abnormal_extraembryonic_tissu | 2.34629867 |
| 19 | MP0010030_abnormal_orbit_morphology | 2.33497462 |
| 20 | MP0003705_abnormal_hypodermis_morpholog | 2.32951636 |
| 21 | MP0002102_abnormal_ear_morphology | 2.30736254 |
| 22 | MP0005408_hypopigmentation | 2.20575699 |
| 23 | MP0008877_abnormal_DNA_methylation | 2.19026809 |
| 24 | MP0001915_intracranial_hemorrhage | 2.16914143 |
| 25 | MP0000653_abnormal_sex_gland | 2.11218512 |
| 26 | MP0008058_abnormal_DNA_repair | 2.09224819 |
| 27 | MP0004859_abnormal_synaptic_plasticity | 2.06526153 |
| 28 | MP0002234_abnormal_pharynx_morphology | 2.02935810 |
| 29 | MP0001929_abnormal_gametogenesis | 2.00150208 |
| 30 | MP0004510_myositis | 1.93185146 |
| 31 | MP0004957_abnormal_blastocyst_morpholog | 1.88970148 |
| 32 | MP0003183_abnormal_peptide_metabolism | 1.87680904 |
| 33 | MP0006072_abnormal_retinal_apoptosis | 1.86257926 |
| 34 | MP0009840_abnormal_foam_cell | 1.79270806 |
| 35 | MP0010234_abnormal_vibrissa_follicle | 1.78763314 |
| 36 | MP0000566_synostosis | 1.76239940 |
| 37 | MP0002210_abnormal_sex_determination | 1.65555974 |
| 38 | MP0002161_abnormal_fertility/fecundity | 1.65517973 |
| 39 | MP0010307_abnormal_tumor_latency | 1.58228638 |
| 40 | MP0001529_abnormal_vocalization | 1.55492829 |
| 41 | MP0001849_ear_inflammation | 1.50469151 |
| 42 | MP0005646_abnormal_pituitary_gland | 1.49604548 |
| 43 | MP0005410_abnormal_fertilization | 1.46967040 |
| 44 | MP0002295_abnormal_pulmonary_circulatio | 1.44702342 |
| 45 | MP0001905_abnormal_dopamine_level | 1.41176532 |
| 46 | MP0009379_abnormal_foot_pigmentation | 1.38425390 |
| 47 | MP0003950_abnormal_plasma_membrane | 1.37296974 |
| 48 | MP0001293_anophthalmia | 1.35392825 |
| 49 | MP0002160_abnormal_reproductive_system | 1.33703755 |
| 50 | MP0000350_abnormal_cell_proliferation | 1.33049325 |
| 51 | MP0001986_abnormal_taste_sensitivity | 1.32694451 |
| 52 | MP0008932_abnormal_embryonic_tissue | 1.28751311 |
| 53 | MP0001485_abnormal_pinna_reflex | 1.23708516 |
| 54 | MP0004142_abnormal_muscle_tone | 1.23481005 |
| 55 | MP0005310_abnormal_salivary_gland | 1.20619134 |
| 56 | MP0003937_abnormal_limbs/digits/tail_de | 1.19924545 |
| 57 | MP0010368_abnormal_lymphatic_system | 1.18390516 |
| 58 | MP0000762_abnormal_tongue_morphology | 1.17313215 |
| 59 | MP0004185_abnormal_adipocyte_glucose | 1.15948109 |
| 60 | MP0003453_abnormal_keratinocyte_physiol | 1.11608025 |
| 61 | MP0008260_abnormal_autophagy | 1.10781469 |
| 62 | MP0000579_abnormal_nail_morphology | 1.09279499 |
| 63 | MP0006276_abnormal_autonomic_nervous | 1.08586627 |
| 64 | MP0002019_abnormal_tumor_incidence | 1.08553602 |
| 65 | MP0002233_abnormal_nose_morphology | 1.07566955 |
| 66 | MP0003698_abnormal_male_reproductive | 1.03857114 |
| 67 | MP0002932_abnormal_joint_morphology | 1.02416646 |
| 68 | MP0003136_yellow_coat_color | 1.01268641 |
| 69 | MP0002272_abnormal_nervous_system | 1.00301699 |
| 70 | MP0008007_abnormal_cellular_replicative | 0.99357702 |
| 71 | MP0005389_reproductive_system_phenotype | 0.99100376 |
| 72 | MP0003890_abnormal_embryonic-extraembry | 0.97117385 |
| 73 | MP0005023_abnormal_wound_healing | 0.96621125 |
| 74 | MP0000639_abnormal_adrenal_gland | 0.95784494 |
| 75 | MP0005360_urolithiasis | 0.94975367 |
| 76 | MP0001664_abnormal_digestion | 0.91797661 |
| 77 | MP0000427_abnormal_hair_cycle | 0.91738722 |
| 78 | MP0008875_abnormal_xenobiotic_pharmacok | 0.89833016 |
| 79 | MP0005647_abnormal_sex_gland | 0.86771908 |
| 80 | MP0001730_embryonic_growth_arrest | 0.86474971 |
| 81 | MP0005085_abnormal_gallbladder_physiolo | 0.86375061 |
| 82 | MP0002085_abnormal_embryonic_tissue | 0.85922063 |
| 83 | MP0003119_abnormal_digestive_system | 0.85272353 |
| 84 | MP0003121_genomic_imprinting | 0.80708539 |
| 85 | MP0001697_abnormal_embryo_size | 0.80560179 |
| 86 | MP0001145_abnormal_male_reproductive | 0.80082245 |
| 87 | MP0002084_abnormal_developmental_patter | 0.77372115 |
| 88 | MP0002933_joint_inflammation | 0.76356289 |
| 89 | MP0000049_abnormal_middle_ear | 0.75926358 |
| 90 | MP0005551_abnormal_eye_electrophysiolog | 0.74987092 |
| 91 | MP0010352_gastrointestinal_tract_polyps | 0.74703675 |
| 92 | MP0003941_abnormal_skin_development | 0.74547133 |
| 93 | MP0000678_abnormal_parathyroid_gland | 0.73290460 |
| 94 | MP0005621_abnormal_cell_physiology | 0.73147487 |
| 95 | MP0002127_abnormal_cardiovascular_syste | 0.71693775 |
| 96 | MP0003868_abnormal_feces_composition | 0.70849443 |
| 97 | MP0001324_abnormal_eye_pigmentation | 0.68258021 |
| 98 | MP0005197_abnormal_uvea_morphology | 0.67559213 |
| 99 | MP0001984_abnormal_olfaction | 0.67348050 |
| 100 | MP0010678_abnormal_skin_adnexa | 0.66053056 |
| 101 | MP0000015_abnormal_ear_pigmentation | 0.65854157 |
| 102 | MP0001963_abnormal_hearing_physiology | 0.63910099 |
| 103 | MP0004145_abnormal_muscle_electrophysio | 0.63123667 |
| 104 | MP0002089_abnormal_postnatal_growth/wei | 0.61986205 |
| 105 | MP0005501_abnormal_skin_physiology | 0.61380466 |
| 106 | MP0002796_impaired_skin_barrier | 0.61232413 |
| 107 | MP0002177_abnormal_outer_ear | 0.60652795 |
| 108 | MP0001502_abnormal_circadian_rhythm | 0.60295447 |
| 109 | MP0001672_abnormal_embryogenesis/_devel | 0.60229418 |
| 110 | MP0005380_embryogenesis_phenotype | 0.60229418 |
| 111 | MP0003329_amyloid_beta_deposits | 0.59355179 |
| 112 | MP0002139_abnormal_hepatobiliary_system | 0.57074236 |
| 113 | MP0000751_myopathy | 0.56727074 |
| 114 | MP0001919_abnormal_reproductive_system | 0.56131563 |
| 115 | MP0001881_abnormal_mammary_gland | 0.54101750 |
| 116 | MP0005075_abnormal_melanosome_morpholog | 0.54018109 |
| 117 | MP0003763_abnormal_thymus_physiology | 0.53909048 |
| 118 | MP0009384_cardiac_valve_regurgitation | 0.53160292 |
| 119 | MP0003566_abnormal_cell_adhesion | 0.51958264 |
| 120 | MP0009697_abnormal_copulation | 0.50088407 |
| 121 | MP0004381_abnormal_hair_follicle | 0.49029923 |
| 122 | MP0001944_abnormal_pancreas_morphology | 0.48035358 |
| 123 | MP0001346_abnormal_lacrimal_gland | 0.47925440 |
| 124 | MP0003315_abnormal_perineum_morphology | 0.47714257 |
| 125 | MP0002168_other_aberrant_phenotype | 0.47437889 |
| 126 | MP0000631_abnormal_neuroendocrine_gland | 0.46419119 |
| 127 | MP0010386_abnormal_urinary_bladder | 0.46026929 |
| 128 | MP0005319_abnormal_enzyme/_coenzyme | 0.45925522 |
| 129 | MP0003632_abnormal_nervous_system | 0.45920331 |
| 130 | MP0005670_abnormal_white_adipose | 0.45707575 |
| 131 | MP0005076_abnormal_cell_differentiation | 0.45545877 |
| 132 | MP0002269_muscular_atrophy | 0.45417511 |
| 133 | MP0008004_abnormal_stomach_pH | 0.43383471 |
| 134 | MP0003959_abnormal_lean_body | 0.43243106 |
| 135 | MP0002735_abnormal_chemical_nociception | 0.43224915 |
| 136 | MP0003075_altered_response_to | 0.43028323 |
| 137 | MP0002249_abnormal_larynx_morphology | 0.42815432 |
| 138 | MP0004043_abnormal_pH_regulation | 0.41305884 |
| 139 | MP0003984_embryonic_growth_retardation | 0.41248720 |
| 140 | MP0005503_abnormal_tendon_morphology | 0.41113164 |
| 141 | MP0005384_cellular_phenotype | 0.40577913 |
| 142 | MP0003755_abnormal_palate_morphology | 0.40140078 |
| 143 | MP0008995_early_reproductive_senescence | 0.39898924 |
| 144 | MP0003195_calcinosis | 0.39774367 |
| 145 | MP0003935_abnormal_craniofacial_develop | 0.39704882 |
| 146 | MP0002734_abnormal_mechanical_nocicepti | 0.39666862 |
| 147 | MP0004233_abnormal_muscle_weight | 0.39494984 |
| 148 | MP0001756_abnormal_urination | 0.38723437 |
| 149 | MP0009763_increased_sensitivity_to | 0.38430896 |
| 150 | MP0000428_abnormal_craniofacial_morphol | 0.38079082 |
| 151 | MP0003252_abnormal_bile_duct | 0.37789085 |
| 152 | MP0002928_abnormal_bile_duct | 0.37720974 |
| 153 | MP0002088_abnormal_embryonic_growth/wei | 0.37667175 |
| 154 | MP0003861_abnormal_nervous_system | 0.37033014 |
| 155 | MP0000733_abnormal_muscle_development | 0.36949256 |
| 156 | MP0004484_altered_response_of | 0.36716977 |
| 157 | MP0006292_abnormal_olfactory_placode | 0.36686183 |
| 158 | MP0001666_abnormal_nutrient_absorption | 0.34579493 |
| 159 | MP0002080_prenatal_lethality | 0.34517030 |
| 160 | MP0000477_abnormal_intestine_morphology | 0.34343151 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cholecystitis (HP:0001082) | 9.70413662 |
| 2 | Abnormal gallbladder physiology (HP:0012438) | 9.70413662 |
| 3 | Deep venous thrombosis (HP:0002625) | 7.13508643 |
| 4 | Osteomalacia (HP:0002749) | 5.42226141 |
| 5 | Abnormality of abdominal situs (HP:0011620) | 5.08033863 |
| 6 | Abdominal situs inversus (HP:0003363) | 5.08033863 |
| 7 | Lip pit (HP:0100267) | 5.00944422 |
| 8 | Impulsivity (HP:0100710) | 4.99200490 |
| 9 | Birth length less than 3rd percentile (HP:0003561) | 4.98200911 |
| 10 | Hypophosphatemic rickets (HP:0004912) | 4.87671980 |
| 11 | Hypoplasia of the fovea (HP:0007750) | 4.85881061 |
| 12 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 4.85881061 |
| 13 | Anterior segment dysgenesis (HP:0007700) | 4.63685364 |
| 14 | Breast hypoplasia (HP:0003187) | 4.49381150 |
| 15 | Supernumerary spleens (HP:0009799) | 4.45099549 |
| 16 | Rhabdomyosarcoma (HP:0002859) | 4.41845525 |
| 17 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 4.29945350 |
| 18 | Abnormality of the fovea (HP:0000493) | 4.05708474 |
| 19 | Infertility (HP:0000789) | 4.01346238 |
| 20 | Septo-optic dysplasia (HP:0100842) | 3.67873176 |
| 21 | Azoospermia (HP:0000027) | 3.67409744 |
| 22 | Apathy (HP:0000741) | 3.62009063 |
| 23 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.59487265 |
| 24 | Hypokinesia (HP:0002375) | 3.57679185 |
| 25 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 3.57146597 |
| 26 | Short 1st metacarpal (HP:0010034) | 3.57146597 |
| 27 | Combined immunodeficiency (HP:0005387) | 3.51341947 |
| 28 | Diminished motivation (HP:0000745) | 3.51240400 |
| 29 | Median cleft lip (HP:0000161) | 3.40180235 |
| 30 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.39440540 |
| 31 | Neoplasm of striated muscle (HP:0009728) | 3.28466969 |
| 32 | Cholelithiasis (HP:0001081) | 3.25593313 |
| 33 | Chromsome breakage (HP:0040012) | 3.22381171 |
| 34 | Abnormality of the labia minora (HP:0012880) | 3.18516275 |
| 35 | Adrenal hypoplasia (HP:0000835) | 3.18389407 |
| 36 | Spinal cord compression (HP:0002176) | 3.11500294 |
| 37 | Papillary thyroid carcinoma (HP:0002895) | 3.09440674 |
| 38 | Abnormality of the 1st metacarpal (HP:0010009) | 3.07428700 |
| 39 | Aplasia/Hypoplasia of the macula (HP:0008059) | 3.07423226 |
| 40 | Abnormal gallbladder morphology (HP:0012437) | 3.04716158 |
| 41 | Muscle stiffness (HP:0003552) | 3.04430167 |
| 42 | Premature ovarian failure (HP:0008209) | 3.04256906 |
| 43 | Gonadotropin excess (HP:0000837) | 3.04165117 |
| 44 | Cortical dysplasia (HP:0002539) | 3.00077670 |
| 45 | Absent septum pellucidum (HP:0001331) | 2.95819830 |
| 46 | Urethral obstruction (HP:0000796) | 2.84891343 |
| 47 | Truncal obesity (HP:0001956) | 2.83020823 |
| 48 | Lower limb hyperreflexia (HP:0002395) | 2.82431713 |
| 49 | Arterial tortuosity (HP:0005116) | 2.81934646 |
| 50 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.80916098 |
| 51 | Aplasia of the musculature (HP:0100854) | 2.79145736 |
| 52 | Abnormal spermatogenesis (HP:0008669) | 2.78363266 |
| 53 | Short tibia (HP:0005736) | 2.76080529 |
| 54 | Loss of speech (HP:0002371) | 2.73444289 |
| 55 | Secondary amenorrhea (HP:0000869) | 2.71714967 |
| 56 | Conjunctival telangiectasia (HP:0000524) | 2.71493112 |
| 57 | Chronic bronchitis (HP:0004469) | 2.70870271 |
| 58 | Skin pits (HP:0100276) | 2.70397173 |
| 59 | Short phalanx of the thumb (HP:0009660) | 2.69336536 |
| 60 | Posterior subcapsular cataract (HP:0007787) | 2.66664704 |
| 61 | Myokymia (HP:0002411) | 2.65311157 |
| 62 | Abnormality of lateral ventricle (HP:0030047) | 2.65041453 |
| 63 | Metaphyseal irregularity (HP:0003025) | 2.64097849 |
| 64 | Generalized aminoaciduria (HP:0002909) | 2.61810812 |
| 65 | Abnormality of chromosome segregation (HP:0002916) | 2.60231709 |
| 66 | Overlapping toe (HP:0001845) | 2.58751360 |
| 67 | Patellar aplasia (HP:0006443) | 2.47796375 |
| 68 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.46796936 |
| 69 | Abnormality of the septum pellucidum (HP:0007375) | 2.44934859 |
| 70 | Fetal akinesia sequence (HP:0001989) | 2.44783831 |
| 71 | Fibular aplasia (HP:0002990) | 2.44602379 |
| 72 | Vascular tortuosity (HP:0004948) | 2.42817873 |
| 73 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.42678549 |
| 74 | Sandal gap (HP:0001852) | 2.42414161 |
| 75 | Proximal tubulopathy (HP:0000114) | 2.41761595 |
| 76 | Oligodactyly (HP:0012165) | 2.41273364 |
| 77 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.40910837 |
| 78 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.39657026 |
| 79 | Uterine leiomyosarcoma (HP:0002891) | 2.39518345 |
| 80 | Leiomyosarcoma (HP:0100243) | 2.39518345 |
| 81 | Diastasis recti (HP:0001540) | 2.39502827 |
| 82 | Thyroid carcinoma (HP:0002890) | 2.38979414 |
| 83 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.36966162 |
| 84 | Dysdiadochokinesis (HP:0002075) | 2.32506471 |
| 85 | Sex reversal (HP:0012245) | 2.30444741 |
| 86 | Abnormal sex determination (HP:0012244) | 2.30444741 |
| 87 | Hypergonadotropic hypogonadism (HP:0000815) | 2.29404081 |
| 88 | Increased circulating renin level (HP:0000848) | 2.24740187 |
| 89 | Intrahepatic cholestasis (HP:0001406) | 2.24188397 |
| 90 | Shawl scrotum (HP:0000049) | 2.23420117 |
| 91 | Abnormality of placental membranes (HP:0011409) | 2.21728667 |
| 92 | Amniotic constriction ring (HP:0009775) | 2.21728667 |
| 93 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.20806771 |
| 94 | Bundle branch block (HP:0011710) | 2.18905740 |
| 95 | Subcapsular cataract (HP:0000523) | 2.18832374 |
| 96 | Anhidrosis (HP:0000970) | 2.18744829 |
| 97 | Embryonal renal neoplasm (HP:0011794) | 2.17963165 |
| 98 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.16187292 |
| 99 | Anomalous pulmonary venous return (HP:0010772) | 2.15412715 |
| 100 | Rib fusion (HP:0000902) | 2.14444166 |
| 101 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.13608699 |
| 102 | Aplasia of the phalanges of the hand (HP:0009802) | 2.13608699 |
| 103 | Aplasia involving bones of the extremities (HP:0009825) | 2.13608699 |
| 104 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.12381707 |
| 105 | Congenital sensorineural hearing impairment (HP:0008527) | 2.12376507 |
| 106 | Hypercortisolism (HP:0001578) | 2.11586368 |
| 107 | Aplasia/Hypoplasia of the breasts (HP:0010311) | 2.11352663 |
| 108 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.11058701 |
| 109 | Breast aplasia (HP:0100783) | 2.10666664 |
| 110 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 2.10137509 |
| 111 | Duodenal stenosis (HP:0100867) | 2.04568854 |
| 112 | Small intestinal stenosis (HP:0012848) | 2.04568854 |
| 113 | Chin dimple (HP:0010751) | 2.04377407 |
| 114 | Sensory axonal neuropathy (HP:0003390) | 2.03869545 |
| 115 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 2.03380796 |
| 116 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.02297606 |
| 117 | Abnormality of the gallbladder (HP:0005264) | 2.02088467 |
| 118 | Abnormal biliary tract physiology (HP:0012439) | 2.00848722 |
| 119 | Bile duct proliferation (HP:0001408) | 2.00848722 |
| 120 | Male infertility (HP:0003251) | 10.0170910 |
| 121 | Nausea (HP:0002018) | 1.99487190 |
| 122 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.99380198 |
| 123 | Abnormality of the intervertebral disk (HP:0005108) | 1.99259473 |
| 124 | Striae distensae (HP:0001065) | 1.99197641 |
| 125 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.98690366 |
| 126 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 1.98401478 |
| 127 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.98361309 |
| 128 | Abnormality of the anterior chamber (HP:0000593) | 1.96678324 |
| 129 | Hypoplastic iliac wings (HP:0002866) | 1.95751121 |
| 130 | Capillary hemangiomas (HP:0005306) | 1.95645909 |
| 131 | Stenosis of the external auditory canal (HP:0000402) | 1.94245143 |
| 132 | Malnutrition (HP:0004395) | 1.93157766 |
| 133 | Microglossia (HP:0000171) | 1.93025032 |
| 134 | Pulmonary fibrosis (HP:0002206) | 1.92860691 |
| 135 | Rickets (HP:0002748) | 1.92658515 |
| 136 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.92001032 |
| 137 | Abnormal lung lobation (HP:0002101) | 1.91480328 |
| 138 | Heterotopia (HP:0002282) | 1.91001668 |
| 139 | Cerebral hypomyelination (HP:0006808) | 1.90129833 |
| 140 | Maternal diabetes (HP:0009800) | 1.89948911 |
| 141 | Abnormal ciliary motility (HP:0012262) | 1.89700859 |
| 142 | Enlarged penis (HP:0000040) | 1.88101778 |
| 143 | Cranial hyperostosis (HP:0004437) | 1.85470397 |
| 144 | Flat capital femoral epiphysis (HP:0003370) | 1.84759278 |
| 145 | Periauricular skin pits (HP:0100277) | 1.83920148 |
| 146 | Preauricular pit (HP:0004467) | 1.83920148 |
| 147 | Spondylolisthesis (HP:0003302) | 1.83231056 |
| 148 | Coxa vara (HP:0002812) | 1.80331536 |
| 149 | Wrist flexion contracture (HP:0001239) | 1.79706251 |
| 150 | Broad alveolar ridges (HP:0000187) | 1.79663128 |
| 151 | Absent hand (HP:0004050) | 1.79177135 |
| 152 | Abnormality of the pulmonary veins (HP:0011718) | 1.78364868 |
| 153 | Decreased circulating renin level (HP:0003351) | 1.78272519 |
| 154 | Hyperactive renin-angiotensin system (HP:0000841) | 1.77454980 |
| 155 | Hydroureter (HP:0000072) | 1.77132384 |
| 156 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.75865210 |
| 157 | Gastrointestinal carcinoma (HP:0002672) | 1.75865210 |
| 158 | Bladder neoplasm (HP:0009725) | 1.74690125 |
| 159 | Bladder carcinoma (HP:0002862) | 1.74690125 |
| 160 | Abnormality of midbrain morphology (HP:0002418) | 1.74320862 |
| 161 | Molar tooth sign on MRI (HP:0002419) | 1.74320862 |
| 162 | Abnormality of the clitoris (HP:0000056) | 1.74094839 |
| 163 | Abnormality of cochlea (HP:0000375) | 1.73921154 |
| 164 | Short thumb (HP:0009778) | 1.73739779 |
| 165 | Neoplasm of the oral cavity (HP:0100649) | 1.73090375 |
| 166 | Oligodactyly (hands) (HP:0001180) | 1.72660811 |
| 167 | Fair hair (HP:0002286) | 1.72222412 |
| 168 | Abnormality of the fingertips (HP:0001211) | 1.71833530 |
| 169 | Increased nuchal translucency (HP:0010880) | 1.70388584 |
| 170 | Abnormality of chromosome stability (HP:0003220) | 1.69710096 |
| 171 | Occipital encephalocele (HP:0002085) | 1.68899316 |
| 172 | Absent forearm bone (HP:0003953) | 1.67403640 |
| 173 | Aplasia involving forearm bones (HP:0009822) | 1.67403640 |
| 174 | Slender long bone (HP:0003100) | 1.65778687 |
| 175 | Generalized myoclonic seizures (HP:0002123) | 1.64970480 |
| 176 | Insidious onset (HP:0003587) | 1.64754808 |
| 177 | Termporal pattern (HP:0011008) | 1.64754808 |
| 178 | Facial hemangioma (HP:0000329) | 1.63949973 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BMPR2 | 9.22301229 |
| 2 | MOS | 8.27743161 |
| 3 | TAOK3 | 5.56655412 |
| 4 | NEK6 | 3.27971178 |
| 5 | LATS1 | 3.19299441 |
| 6 | STK24 | 2.99666201 |
| 7 | LATS2 | 2.63851363 |
| 8 | MAP3K6 | 2.61609812 |
| 9 | TTK | 2.54345409 |
| 10 | CDK12 | 2.46178851 |
| 11 | MAP3K9 | 2.19382467 |
| 12 | MET | 1.97115790 |
| 13 | KSR2 | 1.96941413 |
| 14 | STK38L | 1.93836200 |
| 15 | CDC7 | 1.93733882 |
| 16 | PLK4 | 1.92266839 |
| 17 | STK10 | 1.88436759 |
| 18 | MAP3K13 | 1.77064676 |
| 19 | TRIM28 | 1.64215508 |
| 20 | BUB1 | 1.62649999 |
| 21 | ARAF | 1.62294478 |
| 22 | PRKCI | 1.60381803 |
| 23 | NTRK2 | 1.55768067 |
| 24 | TNIK | 1.41854013 |
| 25 | CDK8 | 1.35424035 |
| 26 | EIF2AK3 | 1.34061681 |
| 27 | CDK9 | 1.33570893 |
| 28 | DYRK2 | 1.33440154 |
| 29 | TAOK1 | 1.29112054 |
| 30 | PTK2 | 1.27242926 |
| 31 | BRSK1 | 1.20030803 |
| 32 | CDK19 | 1.19471034 |
| 33 | RAF1 | 1.03627067 |
| 34 | PIM1 | 1.02356091 |
| 35 | MELK | 1.01498766 |
| 36 | TNK2 | 0.98990833 |
| 37 | CSNK1G1 | 0.96659386 |
| 38 | RET | 0.95604036 |
| 39 | BRAF | 0.89529854 |
| 40 | NEK1 | 0.87426242 |
| 41 | PRKD3 | 0.86021313 |
| 42 | PLK1 | 0.84942318 |
| 43 | NLK | 0.83838643 |
| 44 | MAP3K8 | 0.82367924 |
| 45 | MAP3K4 | 0.82345657 |
| 46 | PAK6 | 0.81213088 |
| 47 | WNK1 | 0.81163531 |
| 48 | MARK3 | 0.75564654 |
| 49 | CSNK1G3 | 0.73572066 |
| 50 | PINK1 | 0.72989727 |
| 51 | CSNK1G2 | 0.71951619 |
| 52 | ZAK | 0.70413617 |
| 53 | NEK2 | 0.69481605 |
| 54 | NTRK3 | 0.67785435 |
| 55 | MST4 | 0.66943921 |
| 56 | STK3 | 0.62884335 |
| 57 | KSR1 | 0.62836302 |
| 58 | STK38 | 0.62782523 |
| 59 | CSNK1A1L | 0.62477647 |
| 60 | LRRK2 | 0.61505680 |
| 61 | NUAK1 | 0.61197022 |
| 62 | ERBB4 | 0.61004408 |
| 63 | BMPR1B | 0.60394641 |
| 64 | PKN2 | 0.58369401 |
| 65 | TIE1 | 0.58056709 |
| 66 | BRSK2 | 0.57361535 |
| 67 | MTOR | 0.56904344 |
| 68 | PRKG1 | 0.55930549 |
| 69 | TRIB3 | 0.55330860 |
| 70 | SRPK1 | 0.54306149 |
| 71 | TGFBR1 | 0.54243880 |
| 72 | HIPK2 | 0.50183420 |
| 73 | PKN1 | 0.48436555 |
| 74 | ABL2 | 0.47803657 |
| 75 | PRKCZ | 0.47162010 |
| 76 | TYRO3 | 0.45005693 |
| 77 | SGK223 | 0.43252698 |
| 78 | SGK494 | 0.43252698 |
| 79 | CHEK2 | 0.43237654 |
| 80 | ATR | 0.41149270 |
| 81 | PDK1 | 0.40350887 |
| 82 | SGK2 | 0.39079134 |
| 83 | AURKB | 0.38750019 |
| 84 | KIT | 0.38720039 |
| 85 | PRKD2 | 0.37727023 |
| 86 | AURKA | 0.37611690 |
| 87 | MAPK13 | 0.36898321 |
| 88 | STK39 | 0.35671875 |
| 89 | MAP2K7 | 0.34106971 |
| 90 | CDK5 | 0.34017346 |
| 91 | NEK9 | 0.33294473 |
| 92 | EPHA3 | 0.29695464 |
| 93 | PLK2 | 0.29353586 |
| 94 | PBK | 0.29293197 |
| 95 | CDK4 | 0.29273236 |
| 96 | MUSK | 0.29080790 |
| 97 | DMPK | 0.26808539 |
| 98 | AKT2 | 0.26442812 |
| 99 | EPHA4 | 0.24746412 |
| 100 | TLK1 | 0.24418490 |
| 101 | PRKAA1 | 0.23575978 |
| 102 | VRK1 | 0.23057605 |
| 103 | MAPK10 | 0.22325470 |
| 104 | EEF2K | 0.21967766 |
| 105 | PDPK1 | 0.21929274 |
| 106 | PRKACA | 0.21240601 |
| 107 | ROCK2 | 0.20894323 |
| 108 | EIF2AK1 | 0.20362185 |
| 109 | CAMK2A | 0.19465576 |
| 110 | MAPK11 | 0.19366163 |
| 111 | MAP2K4 | 0.17729677 |
| 112 | TRPM7 | 0.17386833 |
| 113 | MARK2 | 0.17030512 |
| 114 | SGK3 | 0.16854890 |
| 115 | CHUK | 0.16528798 |
| 116 | CSNK1D | 0.15852708 |
| 117 | CAMK1D | 0.15752610 |
| 118 | ROCK1 | 0.15181121 |
| 119 | CDK11A | 0.15152534 |
| 120 | CLK1 | 0.15045069 |
| 121 | ACVR1B | 0.13398453 |
| 122 | SGK1 | 0.13131372 |
| 123 | MAP3K1 | 0.13111145 |
| 124 | CDK1 | 0.11668137 |
| 125 | MAP2K1 | 0.11398110 |
| 126 | ABL1 | 0.10389539 |
| 127 | MAPKAPK3 | 0.10333806 |
| 128 | MAP3K7 | 0.09444935 |
| 129 | PAK1 | 0.06831462 |
| 130 | PRKAA2 | 0.06138367 |
| 131 | CDK2 | 0.05893378 |
| 132 | PLK3 | 0.05826998 |
| 133 | PNCK | 0.05005770 |
| 134 | ATM | 0.04998376 |
| 135 | CDK7 | 0.04173075 |
| 136 | MAPK1 | 0.03573050 |
| 137 | JAK2 | 0.02704631 |
| 138 | CSNK1A1 | 0.02654628 |
| 139 | ERN1 | 0.02540493 |
| 140 | ADRBK1 | 0.01860489 |
| 141 | PRKACB | 0.01823957 |
| 142 | RPS6KA3 | 0.00525377 |
| 143 | CSNK1E | 0.00376158 |
| 144 | CHEK1 | 0.00191839 |
| 145 | TESK2 | -0.0143234 |
| 146 | EPHB1 | -0.0068238 |
| 147 | MAP3K5 | -0.0054153 |
| 148 | GSK3B | -0.0038408 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 5.78113666 |
| 2 | Oocyte meiosis_Homo sapiens_hsa04114 | 4.34238062 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 3.95515396 |
| 4 | Cell cycle_Homo sapiens_hsa04110 | 3.79183393 |
| 5 | RNA degradation_Homo sapiens_hsa03018 | 3.60799130 |
| 6 | Circadian rhythm_Homo sapiens_hsa04710 | 3.38993698 |
| 7 | Basal transcription factors_Homo sapiens_hsa03022 | 3.16175914 |
| 8 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 3.15857648 |
| 9 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 3.10801148 |
| 10 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.56865101 |
| 11 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.10193751 |
| 12 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.06278143 |
| 13 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 2.05421150 |
| 14 | Pancreatic cancer_Homo sapiens_hsa05212 | 2.00359759 |
| 15 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.99372209 |
| 16 | Base excision repair_Homo sapiens_hsa03410 | 1.79159109 |
| 17 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.76544679 |
| 18 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.57545900 |
| 19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.56951920 |
| 20 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.54809636 |
| 21 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.50986199 |
| 22 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.50262232 |
| 23 | Phototransduction_Homo sapiens_hsa04744 | 1.44082314 |
| 24 | DNA replication_Homo sapiens_hsa03030 | 1.44055466 |
| 25 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.39500516 |
| 26 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.21575067 |
| 27 | Long-term depression_Homo sapiens_hsa04730 | 1.20600892 |
| 28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.10830287 |
| 29 | ABC transporters_Homo sapiens_hsa02010 | 1.07221310 |
| 30 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.06001499 |
| 31 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.04159207 |
| 32 | RNA transport_Homo sapiens_hsa03013 | 0.99098030 |
| 33 | Taste transduction_Homo sapiens_hsa04742 | 0.98491518 |
| 34 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.97320567 |
| 35 | Colorectal cancer_Homo sapiens_hsa05210 | 0.97243377 |
| 36 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.96091790 |
| 37 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.96027656 |
| 38 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.95237514 |
| 39 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.94349370 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.91745328 |
| 41 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.88732427 |
| 42 | Nicotine addiction_Homo sapiens_hsa05033 | 0.88425919 |
| 43 | Morphine addiction_Homo sapiens_hsa05032 | 0.88315405 |
| 44 | Adherens junction_Homo sapiens_hsa04520 | 0.87698424 |
| 45 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.87007235 |
| 46 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.85209318 |
| 47 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.83363651 |
| 48 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.80671221 |
| 49 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.76995475 |
| 50 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.76905969 |
| 51 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.76779715 |
| 52 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.76091317 |
| 53 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.75603298 |
| 54 | GABAergic synapse_Homo sapiens_hsa04727 | 0.75572236 |
| 55 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.73997593 |
| 56 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.73917834 |
| 57 | Thyroid cancer_Homo sapiens_hsa05216 | 0.69700702 |
| 58 | Homologous recombination_Homo sapiens_hsa03440 | 0.69391727 |
| 59 | RNA polymerase_Homo sapiens_hsa03020 | 0.68311340 |
| 60 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.68131492 |
| 61 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.67934708 |
| 62 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.67861734 |
| 63 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.67773059 |
| 64 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.65154141 |
| 65 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.64349256 |
| 66 | Purine metabolism_Homo sapiens_hsa00230 | 0.63878123 |
| 67 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.63571697 |
| 68 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.62138372 |
| 69 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.58576445 |
| 70 | HTLV-I infection_Homo sapiens_hsa05166 | 0.58125513 |
| 71 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.58067833 |
| 72 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.57288141 |
| 73 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.56693485 |
| 74 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.51211553 |
| 75 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.50899625 |
| 76 | Olfactory transduction_Homo sapiens_hsa04740 | 0.49374297 |
| 77 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.47811836 |
| 78 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.46471782 |
| 79 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.45865607 |
| 80 | Gap junction_Homo sapiens_hsa04540 | 0.44450127 |
| 81 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.44008888 |
| 82 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.43369855 |
| 83 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.42785728 |
| 84 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.42561786 |
| 85 | Endometrial cancer_Homo sapiens_hsa05213 | 0.42540444 |
| 86 | Tight junction_Homo sapiens_hsa04530 | 0.41210226 |
| 87 | Bladder cancer_Homo sapiens_hsa05219 | 0.40622911 |
| 88 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39897804 |
| 89 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.39812497 |
| 90 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.39307270 |
| 91 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.38946950 |
| 92 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.37735620 |
| 93 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.37141145 |
| 94 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.35417086 |
| 95 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.34962116 |
| 96 | Long-term potentiation_Homo sapiens_hsa04720 | 0.34544642 |
| 97 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.34093239 |
| 98 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.33182325 |
| 99 | Bile secretion_Homo sapiens_hsa04976 | 0.32276699 |
| 100 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.32175252 |
| 101 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.31556583 |
| 102 | Spliceosome_Homo sapiens_hsa03040 | 0.29746207 |
| 103 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.28573096 |
| 104 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.28004024 |
| 105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.26138473 |
| 106 | Influenza A_Homo sapiens_hsa05164 | 0.25441813 |
| 107 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.24733589 |
| 108 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.24484856 |
| 109 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.24443927 |
| 110 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.24315474 |
| 111 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.23864390 |
| 112 | Glioma_Homo sapiens_hsa05214 | 0.21941910 |
| 113 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.21761180 |
| 114 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.21046386 |
| 115 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.20485104 |
| 116 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.20090043 |
| 117 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.19202201 |
| 118 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.18931692 |
| 119 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.18728935 |
| 120 | Insulin resistance_Homo sapiens_hsa04931 | 0.18229476 |
| 121 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.17631206 |
| 122 | Histidine metabolism_Homo sapiens_hsa00340 | 0.17551419 |
| 123 | Huntingtons disease_Homo sapiens_hsa05016 | 0.17310789 |
| 124 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.16946686 |
| 125 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.16911408 |
| 126 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.16406619 |
| 127 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.15905169 |
| 128 | Hepatitis B_Homo sapiens_hsa05161 | 0.15003091 |
| 129 | Insulin secretion_Homo sapiens_hsa04911 | 0.13558991 |
| 130 | Amoebiasis_Homo sapiens_hsa05146 | 0.11818295 |
| 131 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.11743404 |
| 132 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.10217500 |
| 133 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.09852625 |
| 134 | Circadian entrainment_Homo sapiens_hsa04713 | 0.09677954 |
| 135 | Prostate cancer_Homo sapiens_hsa05215 | 0.09550436 |
| 136 | Phagosome_Homo sapiens_hsa04145 | 0.07652061 |
| 137 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.06881737 |
| 138 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.05275696 |
| 139 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.05248632 |

